Trending News
News
News
PerkinElmer Signs Exclusive Licensing Agreement with Max Planck Innovation for SiPM Technology
Molecular imaging company enhances photon detection offerings with the licensing of low cross-talk solid state silicon photomultiplier technology.
News
Estrogen can Reduce Stroke Damage by Inactivating Protein
Data from researchers at Medical College of Georgia suggets that Estrogen can halt stroke damage by inactivating a tumor-suppressing protein known to prevent many cancers.
News
Domainex Collaborates with St George’s University and The University of Manchester for Asthma Treatment
The £1.5 million collaboration focuses on a new drug discovery programme to provide a better treatment for asthma.
News
Catalyst Biosciences Announces Agreement with MedImmune to Discover and Develop Engineered Protease Therapeutics
Agreement focuses development of novel engineered proteases for the development of drug candidates against two distinct targets.
News
Graceway Pharmaceuticals Acquires Early-stage Dermatological Molecules from Pfizer
Graceway acquires worldwide commercial rights for three investigational dermatological molecules from Pfizer.
News
Engineering Innovative Solutions for 21st Century Medicine
The Wellcome Trust and the Engineering and Physical Sciences Research Council (EPSRC) have announced joint funding for four new Centres of Excellence in Medical Engineering to transform the future of healthcare.
News
Nanostart holding Lumiphore Announces Major new Commercialization Partnership
Lumiphore technology to be used in diagnostic tests from Brahms AG and its subsidiary Cezanne.
News
Parkinson's Disease Society Joins Forces with Healthy Interactions to Launch new Education Programme
The Conversation Map™ tool programme to address the needs of people at all stages of Parkinson’s as well as the needs of their families and carers.
News
Exiqon partners with MedTrust Online to Promote Molecular Oncology Diagnostic Services to Oncologists
Exiqon will provide a comprehensive suite of oncology molecular diagnostics services to MedTrust Online's Oncocentric oncology portal.
News
Celldex Acquires Exclusive Rights to Immune-stimulatory Molecules from Amgen
FMS-like tyrosine kinase 3 ligand and CD40 ligand among assets to be utilized in cancer and anti-inflammatory immunotherapies.
Advertisement